Science 37’s $1.05 Billion de-SPAC Transaction with LifeSci Acquisition II Corp.

Martina Bellini
Tagged:

Latham & Watkins LLP represented Science 37 in the transaction.Science 37, Inc. (Science 37), developer of the Decentralized Clinical Trial Operating SystemTM, and LifeSci Acquisition II…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here